Genetic association between α-synuclein and idiopathic Parkinson's disease

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 7, 2008, Pages 1222-1230

  Kay, Denise M ^a   Factor, Stewart A ^b,c   Samii, Ali ^d,e   Higgins, Donald S ^b   Griffith, Alida ^f   Roberts, John W ^g   Leis, Berta C ^f   Nutt, John G ^h   Montimurro, Jennifer S ^a   Keefe, Robert G ^a   Atkins, April J ^a   Yearout, Dora ^d,e   Zabetian, Cyrus P ^d,e   Payami, Haydeh ^a  

^a WADSWORTH CENTER   (United States)

^b ALBANY MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f Evergreen Hospital Medical Center   (United States)

^g VIRGINIA MASON MEDICAL CENTER   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Age at onset; Mode of inheritance; Relative predispositional effects; REP1; Risk

Indexed keywords

ALPHA SYNUCLEIN; DINUCLEOTIDE; DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; GENE NUMBER; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGE OF ONSET; AGED; ALLELES; ALPHA-SYNUCLEIN; CASE-CONTROL STUDIES; FAMILY HEALTH; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 55349111166     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30758     Document Type: Article

References (26)

1. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A. 2004. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364(9440):1167-1169.
2. Chiba-Falek O, Nussbaum RL. 2001. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet 10(26):3101-3109.
3. Chiba-Falek O, Touchman JW, Nussbaum RL. 2003. Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet 113(5):426-431.
4. Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick T, de Andrade M, West A, de Silva R, Hardy J, Hernandez D. 2001. Alpha-synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 10(17):1847-1851.
5. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW. 2004. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55(2):174-179.
6. Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson EM, Schule B, Langston JW, Middleton FA, Ross OA, Hulihan M, Gasser T, Farrer MJ. 2007. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 68(12):916-922.
7. Gibb WR, Lees AJ. 1988. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752.
8. Hadjigeorgiou GM, Xiromerisiou G, Gourbali V, Aggelakis K, Scarmeas N, Papadimitriou A, Singleton A. 2005. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset. Mov Disord 21(4):534-539.
9. Kruger R, Vieira-Saecker AMM, Kuhn W, Berg D, Muller T, HKuhnl N, Fuchs GA, Storch A, Hungs M, Woitalla D, Przuntek H, Epplen JT, Schols L, Riess O. 1999. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol 45:611-617.
10. Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Kruger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C. 2006. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. J Am Med Assoc 296(6):661-670.
11. Mellick GD, Maraganore DM, Silburn PA. 2005. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease. Neurosci Lett 375(2):112-116.
12. Miller DW, Hague SM, Clarimon J, Baptista M, Gwinn-Hardy K, Cookson MR, Singleton AB. 2004. Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62(10):1835-1838.
13. Mueller JC, Fuchs J, Hofer A, Zimprich A, Lichtner P, Illig T, Berg D, Wullner U, Meitinger T, Gasser T. 2005. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol 57(4):535-541.
14. Pals P, Lincoln S, Manning J, Heckman M, Skipper L, Hulihan M, Van den Broeck M, De Pooter T, Cras P, Crook J, Van Broeckhoven C, Farrer MJ. 2004. Alpha-synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 56:591-595.
15. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP, Cheah JS, Thomson G. 1989. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 45(4):541-546.
16. Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos E, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson W, Lazzarini A, Duvoisin R, Di Iorio G, Golbe L, Nussbaum R. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276(5321):2045-2047.
17. Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H. 2008. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord 23(1):88-95.
18. Reider CR, Halter CA, Castelluccio PF, Oakes D, Nichols WC, Foroud T. 2003. Reliability of reported age at onset for Parkinson's disease. Mov Disord 18(3):275-279.
19. Richards M, Marder K, Cote L, Mayeux R. 1994. Reliability of symptom onset assessment in Parkinson's disease. Mov Disord 9(3):340-342.
20. Ross OA, Gosal D, Stone JT, Lincoln SJ, Heckman MG, Irvine GB, Johnston JA, Gibson JM, Farrer MJ, Lynch T. 2007. Familial genes in sporadic disease: Common variants of alpha-synuclein gene associate with Parkinson's disease. Mech Ageing Dev 128(5-6):378-382.
21. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. 2003. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302(5646):841.
22. Spadafora P, Annesi G, Pasqua AA, Serra P, Ciro Candiano IC, Carrideo S, Tarantino P, Civitelli D, De Marco EV, Nicoletti G, Annesi F, Quattrone A. 2003. NACP-REP1 polymorphism is not involved in Parkinson's disease: A case-control study in a population sample from southern Italy. Neurosci Lett 351(2):75-758.
23. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. 1998. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95(11):6469-6473.
24. Topol EJ, Murray SS, Frazer KA. 2007. The genomics gold rush. JAMA 298(2):218-221.
25. Winkler S, Hagenah J, Lincoln S, Heckman M, Haugarvoll K, Lohmann-Hedrich K, Kostic V, Farrer M, Klein C. 2007. Alpha-synuclein and Parkinson disease susceptibility. Neurology 69(18):1745-1750.
26. Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H. 2007. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol 62(2):137-144.